Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types
- PMID: 7744807
- DOI: 10.1074/jbc.270.19.11678
Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types
Abstract
The type I inositol 1,4,5-trisphosphate (InsP3) receptor can be rapidly depleted from cells during stimulation of phosphoinositide hydrolysis because its degradation is accelerated (Wojcikiewicz, R. J. H., Furuichi, T., Nakade, S., Mikoshiba, K., and Nahorski, S. R. (1994) J. Biol. Chem. 269, 7963-7969). The present study examines the regulatory properties of type II and III InsP3 receptors. Initially, the relative abundance of InsP3 receptors was defined in a range of cell types by quantitative immunoblotting. These studies showed that the proportions in which type I, II, and III InsP3 receptors are expressed differs greatly and that some cells (for example, AR4-2J rat pancreatoma cells) express all three receptors. Analysis of the effects of cholecystokinin and bombesin on AR4-2J cells showed that each of the InsP3 receptors could be down-regulated during activation of phosphoinositide hydrolysis, but that depletion of the type II receptor was limited. Such a discrepancy was also seen in rat cerebellar granule cells and was found to result from the type II receptor being relatively resistant to degradation. In conclusion, type I, II, and III receptors can all be down-regulated, but with different characteristics. As the relative abundance of InsP3 receptors is extremely variable, the extent to which activation of the down-regulatory process alters intracellular signaling will vary depending on which InsP3 receptors are expressed.
Similar articles
-
Differences among type I, II, and III inositol-1,4,5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1,4,5-trisphosphate.Mol Pharmacol. 1998 Apr;53(4):656-62. doi: 10.1124/mol.53.4.656. Mol Pharmacol. 1998. PMID: 9547355
-
Muscarinic receptor activation down-regulates the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation.J Biol Chem. 1994 Mar 18;269(11):7963-9. J Biol Chem. 1994. PMID: 8132516
-
Inositol 1,4,5-trisphosphate receptor down-regulation is activated directly by inositol 1,4,5-trisphosphate binding. Studies with binding-defective mutant receptors.J Biol Chem. 1999 Feb 5;274(6):3476-84. doi: 10.1074/jbc.274.6.3476. J Biol Chem. 1999. PMID: 9920893
-
The inositol 1,4,5-trisphosphate (InsP3) receptor.J Membr Biol. 1995 Jun;145(3):205-16. doi: 10.1007/BF00232713. J Membr Biol. 1995. PMID: 7563022 Review. No abstract available.
-
Inositol 1,4,5-trisphosphate receptors and calcium signaling.Crit Rev Neurobiol. 1996;10(1):39-55. doi: 10.1615/critrevneurobiol.v10.i1.20. Crit Rev Neurobiol. 1996. PMID: 8853953 Review.
Cited by
-
Characterization of the C. elegans erlin homologue.BMC Cell Biol. 2012 Jan 23;13:2. doi: 10.1186/1471-2121-13-2. BMC Cell Biol. 2012. PMID: 22269071 Free PMC article.
-
Novel regulation of calcium inhibition of the inositol 1,4,5-trisphosphate receptor calcium-release channel.J Gen Physiol. 2003 Nov;122(5):569-81. doi: 10.1085/jgp.200308808. J Gen Physiol. 2003. PMID: 14581583 Free PMC article.
-
Endogenous Bok is stable at the endoplasmic reticulum membrane and does not mediate proteasome inhibitor-induced apoptosis.Front Cell Dev Biol. 2022 Dec 19;10:1094302. doi: 10.3389/fcell.2022.1094302. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36601536 Free PMC article.
-
Redox regulation of type-I inositol trisphosphate receptors in intact mammalian cells.J Biol Chem. 2018 Nov 9;293(45):17464-17476. doi: 10.1074/jbc.RA118.005624. Epub 2018 Sep 18. J Biol Chem. 2018. PMID: 30228182 Free PMC article.
-
Calcium-dependent clustering of inositol 1,4,5-trisphosphate receptors.Mol Biol Cell. 1998 Jun;9(6):1465-78. doi: 10.1091/mbc.9.6.1465. Mol Biol Cell. 1998. PMID: 9614187 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials